Dr. Scott Furlan studies the biology of blood stem cell transplantation and cellular immunotherapy for people with cancers and other diseases. He is learning how immune cells, such as T cells, behave during and after treatment, and how changes in immune cell behavior affect treatment outcomes. He aims to use what he learns improve transplantation and T-cell therapies for children. Dr. Furlan employs a method called single-cell genomics, which reveals an unprecedented level of detail about the individual cells in a sample. This technique shows him how immune cells respond to new biological surroundings, or microenvironments, throughout treatment. One particular research focus is immune dysfunction in graft-vs.-host disease, in which transplanted donor immune cells attack a patient’s healthy tissues. He also focuses on learning how to improve T-cell therapy and how transplanted donor immune cells affect cancers.
Seattle Children’s Research Institute 2012-2015, Post-doctoral Fellowship - Transplant Immunology
UT Southwestern Medical Center 2009-2012, Fellowship - Pediatric Hematology Oncology
UT Southwestern Medical Center 2006-2009, Residency - Pediatrics
Keck School of Medicine at USC, 2002-2006, MD
Macalester College 1994-1998, Bachelor of Arts
Transcriptomics and epigenomics of graft-versus-host disease and immune reconstitution post hematopoietic cell transplantation
Acute Myelogenous Leukemia
Adoptive cellular therapy
Hematopoietic Cell Transplantation
Pediatric Oncology
Acute Myelogenous Leukemia
— Dr. Scott Nicholas Furlan
